FDA Recall of Additional Potassium Capsules - MedWaste Management FDA Recall of Additional Potassium Capsules - MedWaste Management

Medical Waste and the Healthcare Industry Blog

Stay tuned to our blog for timely updates and insights into the ever-evolving landscape of medical waste news and developments.

FDA Recall Potassium Chloride K+ Extended Release

FDA Recall of Additional Potassium Capsules

Earlier this week, the FDA announced a recall of extended-release Potassium Chloride capsules due to a failure to dissolve as intended. When functioning properly, the drug is slowly released into the patient’s system, allowing for proper processing. However, failure of the dissolution process may lead to sudden release of the entirety of the capsule, causing severe and dangerous health outcomes.

Now, the FDA has added 21 additional lots to the recall list for this medication. These lots were manufactured and distributed by Blue Point Laboratories.

As of the writing of this notice, the FDA has not announced any adverse events related to the contamination.

SUMMARY

Date of Recall:

Announced: June 25, 2024

Public Notification: June 26, 2024

Name(s) of Drug:

Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K

Company Name:

American Health Packaging

Blue Point Laboratories

Drug Indication:

Potassium Supplementation

FDA Recall Potassium Chloride K+ Extended Release Package
FDA Recall Potassium Chloride K+ Extended Release Package

Product Description

Potassium Chloride Extended-Release Capsules are available by prescription only. Pharmacies nationwide distributed the capsules to the facility and consumer levels. Each was packaged in either 100-count or 500-count bottles and labeled clearly with a teal, blue, and white label. The NDC number, expiration date, batch number, and product name are clearly printed on the package.

Reason for Recall

American Health Packaging is voluntarily initiating the recall. They have not publicly stated how the failed dissolution was discovered, but the FDA report states that no serious adverse events have been reported as a result of the failure.

Impacts

Consumers who continue to use the faulty drug may experience serious health outcomes related to a sudden increase in their potassium levels. High potassium levels may lead to effects such as:

  • Irregular heartbeat
  • Cardiac arrest (heart attack)
  • Severe muscle weakness
  • Death

Recall Lot Information

All medical facilities and distributors who stock Potassium Chloride Capsules and consumers who take the capsules must carefully examine their inventory to determine if their product is included in the recall. Compare each bottle’s NDC, lot numbers, strength, and expiration date to the chart below. If any are found to match, read further for instructions on participating in the recall.

Sr. NoNDCProduct NameBatch No.Expiry Date
1.68001-396-00Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 100 count
1722173807/31/2024
2.68001-396-00Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 100 count
1722249410/31/2024
3.68001-396-00Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 100 count
1723053301/31/2025
4.68001-396-00Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 100 count
1723220809/30/2025
5.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1722182307/31/2024
6.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1722183007/31/2024
7.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1722183108/31/2024
8.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723024812/31/2024
9.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723025312/31/2024
10.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723027112/31/2024
11.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723079602/28/2025
12.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723082002/28/2025
13.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723082503/31/2025
14.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723083303/31/2025
15.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723084003/31/2025
16.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723153706/30/2025
17.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 50 count
1723154006/30/2025
18.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723171906/30/2025
19.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723173706/30/2025
20.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 500 count
1723211109/30/2025
21.68001-396-03Potassium Chloride Extended-Release Capsules USP
(750 mg) 10 mEQ K – 50 count
1723216409/30/2025

FDA.gov

Have you found that your medication is part of the recall? Here’s what you should do:

Consumer Recall Instructions

If you find that your lot of medication is part of this recall, do the following:

  1. Do not take the recalled medication.
  2. Ask your doctor to replace the recalled drug with a new bottle. If the lot number, NDC number, and expiration date do not match the chart, the medication is not included in this recall.
  3. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.

Healthcare System Recall Instructions

  1. Examine all inventory and remove stock affected by the recall immediately.
  2. If you have questions, contact Sedgwick at 1-855-695-8564. They are available from 8 a.m. to 5 p.m. EST, Monday through Friday.
  3. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

Wholesaler/Retailer Recall Instructions

  1. Examine all inventory and remove stock affected by the recall immediately.
  2. If you have questions, contact Sedgwick at 1-855-695-8564. They are available from 8 a.m. to 5 p.m. EST, Monday through Friday. Notify them of recalled batches that have already been shipped to medical facilities or distributed to consumers.
  3. Notify affected medical facilities and consumers of recalled batches that they have already or will receive.
  4. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal in the healthcare industry and the general public. We publish this blog to spread useful and practical information to help you stay safe, smart, and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services 

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store Learn How To Properly Manage & Dispose of Household Medical Waste

Tammy McKinney, Nurse Writer Healthcare Content Creator Byline Image

Tammy McKinney, RN, founder of HelpfulHospiceNurse, is a healthcare writer and seasoned registered nurse. With experience in acute care, long-term care, rehabilitation, drug & alcohol, and hospice & palliative care, she combines her medical understanding with her love for writing to educate and inform the public on various health-related topics. You can view a snippet of her portfolio here or contact her directly on LinkedIn!

I know I can count on you all to collect everything and do it safely.

You are a great company to work with. At our pharmaceutical production laboratory. We have gallons of leftover pharmaceutical waste that are a headache for our techs to deal with. I know I can count on you all to collect everything and do it safely. I’m pleased with the personal service.

M

Mitchell Adam

Got questions? Need our services?

We’ll get back to you by tomorrow — latest!

Fill the form